Expression of interferon consensus sequence binding protein induces potent immunity against BCR/ABL-induced leukemia

RAG-1-deficient mice have no mature B and T lymphocytes

Mombaerts, P., Iacomini, J., Johnson, R. S., Herrup, K., Tonegawa, S., & Papaioannou, V. E. (1992) · Cell · doi:10.1016/0092-8674(92)90030-g · Cited by 2,898 · see citing works

CELLULAR RESPONSES TO INTERFERON-γ

Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890 · see citing works

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

Dranoff, G., Jaffee, E. M., Lazenby, A., Golumbek, P. T., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D. M., & Mulligan, R. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3539 · Cited by 2,803 · see citing works

Chronic Myeloid Leukemia

Sawyers, C. L. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904293401706 · Cited by 1,615 · see citing works

Multiple defects in innate and adaptive immunologic function in NOD/LtSz- scid mice.

Shultz, L. D., Schweitzer, P. A., Christianson, S. W., Gott, B., Schweitzer, I. B., Tennent, B. J., McKenna, S., Mobraaten, L. E., Rajan, T. V., Greiner, D. L., et al. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.1.180 · Cited by 1,224 · see citing works

IL3-dependent mouse clones that express B-220 surface antigen, contain ig genes in germ-line configuration, and generate B lymphocytes in vivo

Palacios, R., & Steinmetz, M. (1985) · Cell · doi:10.1016/s0092-8674(85)80053-2 · Cited by 716 · see citing works

Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia

Molldrem, J. J., Lee, P. P., Wang, C., Felio, K., Kantarjian, H. M., Champlin, R. E., & Davis, M. M. (2000) · Nature Medicine · doi:10.1038/79526 · Cited by 670 · see citing works

Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development

Matsuyama, T., Kimura, T., Kitagawa, M., Pfeffer, K., Kawakami, T., Watanabe, N., Kündig, T. M., Amakawa, R., Kishihara, K., Wakeham, A., et al. (1993) · Cell · doi:10.1016/s0092-8674(05)80086-8 · Cited by 649 · see citing works

Immunodeficiency and Chronic Myelogenous Leukemia-like Syndrome in Mice with a Targeted Mutation of the ICSBP Gene

Holtschke, T., Löhler, J., Kanno, Y., Fehr, T., Giese, N., Rosenbauer, F., Lou, J., Knobeloch, K.-P., Gabriele, L., Waring, J. F., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81348-3 · Cited by 644 · see citing works

Interferon regulatory factors: the next generation

Mamane, Y., Heylbroeck, C., Génin, P., Algarté-Génin, M., Servant, M. J., Page, C. L., DeLuca, C., Kwon, H., Lin, R., & Hiscott, J. B. (1999) · Gene · doi:10.1016/s0378-1119(99)00262-0 · Cited by 570 · see citing works

Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein.

Daley, G. Q., & Baltimore, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9312 · Cited by 563 · see citing works

An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes.

Driggers, P. H., Ennist, D. L., Gleason, S. L., Mak, W. H., Marks, M. S., Levi, B. Z., Flanagan, J. R., Appella, E., & Ozato, K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3743 · Cited by 356 · see citing works

ICSBP Directs Bipotential Myeloid Progenitor Cells to Differentiate into Mature Macrophages

Tamura, T., Nagamura-Inoue, T., Shmeltzer, Z., Kuwata, T., & Ozato, K. (2000) · Immunity · doi:10.1016/s1074-7613(00)00016-9 · Cited by 305 · see citing works

Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responses

Pinilla-Ibarz, J. A., Cathcart, K. N. S., Korontsvit, T., Soignet, S. L., Bocchia, M., Caggiano, J., Lai, L. T., Jiménez, J. L., Kolitz, J. E., & Scheinberg, D. A. (2000) · Blood · doi:10.1182/blood.v95.5.1781.005k46_1781_1787 · Cited by 245 · see citing works

PU.1 and Interferon Consensus Sequence-binding Protein Regulate the Myeloid Expression of the Human Toll-like Receptor 4 Gene

Rehli, M., Poltorak, A., Schwarzfischer, L., Krause, S. W., Andreesen, R., & Beutler, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9773 · Cited by 233 · see citing works

Interferon Consensus Sequence Binding Protein–deficient Mice Display Impaired Resistance to Intracellular Infection Due to a Primary Defect in Interleukin 12 p40 Induction

Scharton-Kersten, T., Contursi, C., Masumi, A., Sher, A., & Ozato, K. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1523 · Cited by 217 · see citing works

Lack of Interferon Consensus Sequence Binding Protein (ICSBP) Transcripts in Human Myeloid Leukemias

Schmidt, M., Nagel, S., Proba, J., Thiede, C., Ritter, M., Waring, J. F., Rosenbauer, F., Huhn, D., Wittig, B., Horak, I., et al. (1998) · Blood · doi:10.1182/blood.v91.1.22 · Cited by 199 · see citing works

Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription.

Nelson, N., Marks, M. S., Driggers, P. H., & Ozato, K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.588 · Cited by 192 · see citing works

Interferon Consensus sequence-Binding Protein, a Member of the Interferon Regulatory Factor Family, Suppresses Interferon-Induced Gene Transcription

Nelson, N., Marks, M. S., Driggers, P. H., & Ozato, K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.588-599.1993 · Cited by 192 · see citing works

An IFN-γ-Inducible Transcription Factor, IFN Consensus Sequence Binding Protein (ICSBP), Stimulates IL-12 p40 Expression in Macrophages

Wang, I.-M., Contursi, C., Masumi, A., Ma, X., Trinchieri, G., & Ozato, K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.271 · Cited by 187 · see citing works

Interactions between mycoplasma lipoproteins and the host immune system

Chambaud, I., Wróblewski, H., & Blanchard, A. (1999) · Trends in Microbiology · doi:10.1016/s0966-842x(99)01641-8 · Cited by 180 · see citing works

Interferon (IFN) Consensus Sequence-binding Protein, a Transcription Factor of the IFN Regulatory Factor Family, Regulates Immune Responses In Vivo through Control of Interleukin 12 Expression

Giese, N. A., Gabriele, L., Doherty, T. M., Klinman, D. M., Tadesse-Heath, L., Contursi, C., Epstein, S. L., & Morse, H. C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1535 · Cited by 160 · see citing works

Protein-Protein and DNA-Protein Interactions Affect the Activity of Lymphoid-Specific IFN Regulatory Factors

Meraro, D., Hashmueli, S., Koren, B., Azriel, A., Oumard, A., Kirchhoff, S., Hauser, H., Nagulapalli, S., Atchison, M. L., & Levi, B.-Z. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6468 · Cited by 147 · see citing works

Expression of Interferon Consensus Sequence Binding Protein (ICSBP) Is Downregulated in Bcr-Abl-Induced Murine Chronic Myelogenous Leukemia-Like Disease, and Forced Coexpression of ICSBP Inhibits Bcr-Abl-Induced Myeloproliferative Disorder

Hao, S. X., & Ren, R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1149-1161.2000 · Cited by 143 · see citing works

Recruitment of CREB-binding protein by PU.1, IFN-regulatory factor-1, and the IFN consensus sequence-binding protein is necessary for IFN-gamma-induced p67phox and gp91phox expression.

Eklund, E. A., & Kakar, R. (1999) · PubMed · Cited by 124 · see citing works

Mycoplasmal Infections Prevent Apoptosis and Induce Malignant Transformation of Interleukin-3-Dependent 32D Hematopoietic Cells

Feng, S.-H., Tsai, S., Rodriguez, J., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.7995 · Cited by 119 · see citing works

Peptide Antagonism and T Cell Receptor Interactions with Peptide-MHC Complexes

Sykulev, Y. K., Vugmeyster, Y., Brunmark, A. B., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80631-7 · Cited by 115 · see citing works

Regulation of Apoptosis in Myeloid Cells by Interferon Consensus Sequence–Binding Protein

Gabriele, L., Phung, J., Fukumoto, J., Segal, D., Wang, I.-M., Giannakakou, P., Giese, N. A., Ozato, K., & Morse, H. C. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.3.411 · Cited by 114 · see citing works

Recruitment of CREB-Binding Protein by PU.1, IFN-Regulatory Factor-1, and the IFN Consensus Sequence-Binding Protein Is Necessary for IFN-γ-Induced p67 <i>phox</i> and gp91 <i>phox</i> Expression

Eklund, E. A., & Kakar, R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6095 · Cited by 113 · see citing works

Altered Development and Cytokine Responses of Myeloid Progenitors in the Absence of Transcription Factor, Interferon Consensus Sequence Binding Protein

Scheller, M., Foerster, J., Heyworth, C. M., Waring, J. F., Löhler, J., Gilmore, G. L., Shadduck, R. K., Dexter, T. M., & Horak, I. (1999) · Blood · doi:10.1182/blood.v94.11.3764 · Cited by 111 · see citing works

Role of B7-1 in mediating an immune response to myeloid leukemia cells

Matulonis, U. A., Dosiou, C., Lamont, C., Freeman, G., Mauch, P. M., Nadler, L. M., & Griffin, J. D. (1995) · Blood · doi:10.1182/blood.v85.9.2507.bloodjournal8592507 · Cited by 108 · see citing works

Mechanisms of the Graft‐versus‐Leukemia Reaction

Barrett, A. J. (1997) · Stem Cells · doi:10.1002/stem.150248 · Cited by 94 · see citing works

Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies.

Talpaz, M., Estrov, Z., Kantarjian, H. M., Ku, S., Foteh, A., & Kurzrock, R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117473 · Cited by 91 · see citing works

Persistence of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-α therapy or allogeneic bone marrow transplantation

Chomel, J., Brizard, F., Veinstein, A., Rivet, J., Sadoun, A., Kitzis, A., Guilhot, F., & Brizard, A. (2000) · Blood · doi:10.1182/blood.v95.2.404 · Cited by 89 · see citing works

Variable numbers of BCR‐ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon‐α

Hochhaus, A., Lin, F., Reiter, A., et al. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05257.x · Cited by 81 · see citing works

IFN consensus sequence binding protein potentiates STAT1-dependent activation of IFNγ-responsive promoters in macrophages

Contursi, C., Wang, I.-M., Gabriele, L., Gadina, M., O'Shea, J., Morse, H. C., & Ozato, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.91 · Cited by 72 · see citing works

Vaccines With Interleukin-12–Transduced Acute Myeloid Leukemia Cells Elicit Very Potent Therapeutic and Long-Lasting Protective Immunity

Dunussi‐Joannopoulos, K., Runyon, K., Erickson, J., Schaub, R. G., Hawley, R. G., & Leonard, J. P. (1999) · Blood · doi:10.1182/blood.v94.12.4263.424k30_4263_4273 · Cited by 67 · see citing works

Effect of gamma radiation on resting B lymphocytes. II. Functional characterization of the antigen-presentation defect.

Ashwell, J. D., Jenkins, M. K., & Schwartz, R. H. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.8.2536 · Cited by 62 · see citing works

CML vaccines as a paradigm of the specific immunotherapy of cancer

Pinilla-Ibarz, J. A., Cathcart, K. N. S., & Scheinberg, D. A. (2000) · Blood Reviews · doi:10.1054/blre.2000.0127 · Cited by 51 · see citing works

IFN consenus sequence binding protein (ICSBP) is a conditional repressor of IFN inducible promoters

Welsz, A., Kirchhoff, S., & Levi, B.-Z. (1994) · International Immunology · doi:10.1093/intimm/6.8.1125 · Cited by 50 · see citing works

BCR/ABL mRNA and the P210BCR/ABL Protein Are Downmodulated by Interferon- in Chronic Myeloid Leukemia Patients

Pane, F., Mostarda, I., Selleri, C., et al. (1999) · Blood · doi:10.1182/blood.v94.7.2200.419a33_2200_2207 · Cited by 49 · see citing works

The Effect of Interferon-α on Beta-1 Integrin Mediated Adhesion and Growth Regulation in Chronic Myelogenous Leukemia

Bhatia, R., & Verfaillie, C. M. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809092680 · Cited by 40 · see citing works

Persistent donor chimaerism is consistent with disease-free survival following BMT for chronic myeloid leukaemia

Gardiner, N., Lawler, M., O’Riordan, J., et al. (1997) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1700861 · Cited by 39 · see citing works

Relative Roles of Natural Killer- and T Cell-Mediated Anti-Leukemia Effects in Chronic Myelogenous Leukemia Patients Treated with Interferon-α

Pawelec, G., da Silva, P., Max, H., et al. (1995) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199509059647 · Cited by 39 · see citing works

Evidence for specific immune response against P210 BCR-ABL in long-term remission CML patients treated with interferon

Oka, T., Sastry, K. J., Nehete, P. N., et al. (1998) · Leukemia · doi:10.1038/sj.leu.2400919 · Cited by 32 · see citing works

Interferon-alpha: mechanisms of action in chronic myelogenous leukemia in chronic phase.

Guilhot, F., & Lacotte‐Thierry, L. (1998) · PubMed · Cited by 27 · see citing works

BCR‐ABL‐positive progenitors in chronic myeloid leukaemia patients in complete cytogenetic remission after treatment with interferon‐α

Reiter, A., Marley, S. B., Hochhaus, A., et al. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00905.x · Cited by 23 · see citing works

The IRF Family Transcription Factors in Immunity and Oncogenesis

Tamura, T., Yanai, H., Savitsky, D., & Taniguchi, T. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090400 · Cited by 1,259 · see citing works

The IRF family of transcription factors: Inception, impact and implications in oncogenesis

Yanai, H., Negishi, H., & Taniguchi, T. (2012) · OncoImmunology · doi:10.4161/onci.22475 · Cited by 261 · see citing works

Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells

Tamura, T., & Ozato, K. (2002) · Journal of Interferon &amp; Cytokine Research · doi:10.1089/107999002753452755 · Cited by 183 · see citing works

Application of a bcr-specific probe in the classification of human leukaemia

Boehm, T. L. J., & Drahovský, D. (1987) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf00396384 · Cited by 7 · see citing works

Distribution of breakpoint within the breakpoint cluster region (bcr) in chronic myelogenous leukemia with a complex philadelphia chromosome translocation

Nishigaki, H., Inazawa, J., Misawa, S., et al. (1989) · American Journal of Hematology · doi:10.1002/ajh.2830320307 · Cited by 7 · see citing works

The Study of Cortex Periplocae Extract on the Differentiation of K562 Cells

Shan, B. (2008) · Carcinogenesis,Teratogenesis and Mutagenesis · Cited by 1 · see citing works

Location of breakpoints within the major breakpoint cluster region (bcr) in 33 patients with bcr rearrangement‐positive chronic myeloid leukemia (CML) with complex or absent Philadelphia chromosomes

Dubé, I. D., Dixon, J. E., Beckett, T. A., et al. (1989) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870010116 · Cited by 33 · see citing works

Sorafenib Combined with Recombinant Human TRAIL on Growth Inhibition Effects and Inducing Apoptosis of Leukemia Cells of K562

Ahu, W. (2014) · Journal of Jianghan University